Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel sulfonate-mediated route for 5-bromo-7-azaindole offers high purity and cost efficiency for oncology drug development.
Novel 7-step route for MI-2 key intermediate. Mild conditions, high purity. Reliable pharmaceutical intermediates supplier for oncology research.
Patent CN103772213A details a room-temperature copper-catalyzed route for (2S,3S)-2-amino-octadec-1,3-diol, offering significant cost reduction and high stereoselectivity for API manufacturing.
Patent CN112930348A details an enzymatic route for Safraninib, improving yield and reducing waste compared to chiral resolution methods.
Patent CN110606842B discloses a high-yield, environmentally friendly process for EGFR inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel preparation method for anticancer semicarbazide derivatives via CN110156672B. High yield, low cost process suitable for industrial scale-up and API manufacturing.
Patent CN111233949A details a novel one-pot three-enzyme method for GM3 synthesis, offering high stereoselectivity and cost reduction for pharmaceutical intermediate manufacturing.
Novel bromination process for 6-bromo-2-chloro-8-cyclopentyl-5-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one ensures high yield and low impurities for reliable supply chain.
Patent CN119654332A reveals a stereoselective route for DNMT1 inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111892591A reveals a novel DMAP-catalyzed route for Venetoclax intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN101274923B reveals a novel nitrate-catalyzed method for selective acylation, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101497639B details a scalable Decitabine synthesis using toluoyl protection and fractional crystallization, offering significant cost reduction in pharmaceutical manufacturing.
Advanced preparation of c-Met inhibitor intermediates via Pd-catalyzed coupling. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN112250611B reveals a novel Friedel-Crafts route for Larotrectinib intermediates. Achieve high purity and cost reduction in API manufacturing with scalable chemistry.
Advanced synthesis of low-cardiotoxicity anthracycline intermediates via novel reductive amination. Optimized for scale-up and purity in API manufacturing.
Novel salt-formation purification method for Letrozole eliminates isomers without chromatography, ensuring high purity and cost-effective manufacturing for global supply chains.
Patent CN110511214A reveals a ruthenium-catalyzed route for diamine heterocycles, offering cost reduction and scalable supply for antitumor pharmaceutical intermediates.
Novel preparation method of Neratinib avoiding toxic chlorination. Cost-effective, scalable API intermediate manufacturing process for pharmaceutical supply chains.
Patent CN103288804A reveals a streamlined one-step condensation for Nilotinib, offering superior atom economy and simplified supply chains for API manufacturers.
Novel semi-synthetic process for taxane derivatives using activated oxazoles. Offers improved yield and purity for API manufacturing.